Paper456408
The protein binding of methotrexate by the serum of normal subjects.
Steele WH and 3 others. Eur J Clin Pharmacol, 1979. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The protein binding of methotrexate by the serum of normal subjects. Papers, record 456408. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/456408
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Proteins | Major topic |
| Methotrexate | Major topic |
| Humans | |
| Kinetics | |
| Protein Binding |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,349,626 | The effect of organic acids on renal clearance of methotrexate in man. | Clin Pharmacol Ther | 1969 | https://conductscience.org/library/papers/5349626 | PubMed |
| 2 | 1,085,404 | Methotrexate megadosage followed by folate rescue. I. A study in clearance patterns. | Med J Aust | 1976 | https://conductscience.org/library/papers/1085404 | PubMed |
| 3 | 4,539,306 | Recent advances in the chemotherapy of metastatic osteogenic sarcoma. | Cancer | 1972 | https://conductscience.org/library/papers/4539306 | PubMed |
| 4 | 4,541,737 | Improved therapeutic index of methotrexate with "leucovorin rescue". | Cancer Res | 1973 | https://conductscience.org/library/papers/4541737 | PubMed |
| 5 | 333,910 | High-dose methotrexate with folinic acid rescue. | Am J Hosp Pharm | 1977 | https://conductscience.org/library/papers/333910 | PubMed |
| 6 | 688,614 | Comparison of three radioligands, selenium-75, lodine-125, and tritium, in the radioimmunoassay of methotrexate. | Clin Chem | 1978 | https://conductscience.org/library/papers/688614 | PubMed |
| 7 | 4,298,056 | Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. | Cancer Res | 1968 | https://conductscience.org/library/papers/4298056 | PubMed |
| 8 | 778,295 | Cytokinetics and chemotherapy of psoriasis. | J Invest Dermatol | 1976 | https://conductscience.org/library/papers/778295 | PubMed |
| 9 | 1,001,358 | Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances. | Eur J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/1001358 | PubMed |
| 10 | 1,182,676 | Evaluation of methotrexate in the treatment of bronchogenic carcinoma. | Cancer | 1975 | https://conductscience.org/library/papers/1182676 | PubMed |
| 11 | 5,410,994 | Intermittent high dose oral methotrexate therapy in psoriasis. | Br J Dermatol | 1970 | https://conductscience.org/library/papers/5410994 | PubMed |
| 12 | 978,453 | Effects of plasma protein binding of drugs on duration and intensity of pharmacological activity. | J Pharm Sci | 1976 | https://conductscience.org/library/papers/978453 | PubMed |
| 13 | 5,886,217 | Potential effect of the plasma on drug distribution. | Nature | 1965 | https://conductscience.org/library/papers/5886217 | PubMed |
| 14 | 4,248,129 | Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue". | Cancer Res | 1970 | https://conductscience.org/library/papers/4248129 | PubMed |
| 15 | 4,813,248 | Measurement of drug displacement by continuous ultrafiltration. | J Pharm Sci | 1974 | https://conductscience.org/library/papers/4813248 | PubMed |
| 16 | 47,611 | The clinical pharmacology of antineoplastic agents (second of two parts). | N Engl J Med | 1975 | https://conductscience.org/library/papers/47611 | PubMed |
| 17 | 856,048 | Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding. | Arch Dermatol | 1977 | https://conductscience.org/library/papers/856048 | PubMed |
| 18 | 4,954,195 | The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys. | Cancer Res | 1965 | https://conductscience.org/library/papers/4954195 | PubMed |
| 19 | 668,796 | Apparent volumes of distribution and drug binding to plasma proteins and tissues. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/668796 | PubMed |
| 20 | 1,107,839 | Binding of drugs to serum albumin (first of two parts). | N Engl J Med | 1976 | https://conductscience.org/library/papers/1107839 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,236,714 | Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup. | Clin J Am Soc Nephrol | 2022 | https://conductscience.org/library/papers/35236714 | PubMed |
| 21,841,039 | Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models. | Drug Metab Dispos | 2011 | https://conductscience.org/library/papers/21841039 | PubMed |
| 8,793,258 | Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. | Clin Rheumatol | 1996 | https://conductscience.org/library/papers/8793258 | PubMed |
| 8,777,850 | Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. | Clin Rheumatol | 1996 | https://conductscience.org/library/papers/8777850 | PubMed |
| 7,628,046 | Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7628046 | PubMed |
| 7,340,989 | The protein binding of methotrexate in the serum of patients with neoplastic disease. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7340989 | PubMed |
| 6,668,557 | Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion. | J Pharmacokinet Biopharm | 1983 | https://conductscience.org/library/papers/6668557 | PubMed |
| 6,189,661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 3,582,482 | Melphalan concentration dependent plasma protein binding in healthy humans and rats. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3582482 | PubMed |
| 2,191,847 | Antineoplastic drugs in 1990. A review (Part II). | Drugs | 1990 | https://conductscience.org/library/papers/2191847 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/456408
GET https://conductscience.org/api/papers/v1/456408/references?page=2